Patent AnalyticsExaminers
Menu

Application

17414672 · N-(pyridin-2-ylsulfonyl)cyclopropanecarboxamide Derivatives and their Use in the Treatment of Disease

Filed 2021-06-16 · Abandoned The official file ↗ · Art unit 1625 · Examiner Gillian A Hutter Hard · CPC C07D 213/73 · NOVARTIS AG · NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, INC.

Office actions
0
first was Restriction requirement
RCEs
0
no appeal
To first action
33.7 mo
to disposition 42.2 mo
Statutes raised
·
0 actions read
Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in